As such, BA was found to reduce endothelial dysfunction by increasing the expression of endothelial nitric oxide synthase (eNOS), which further inhibited the expression of intracellular adhesion molecule-1 (ICAM-1) and endothelin-1 (ET-1) that promote the atherosclerotic plaque formation [76]. The gene discussed is EDN1; the disease is endothelial dysfunction.